5.15
5.15 (0%)
As of Feb 14, 2025
Cumberland Pharmaceuticals Inc [CPIX]
Source:
Company Overview
Cumberland Pharmaceuticals Inc. is a specialty pharmaceutical company focused on the acquisition, development and commercialization of branded prescription pharmaceuticals. We are dedicated to our mission of working together to provide unique products that improve the quality of patient care.
| Country | United States |
| Headquarters | nashville, tennessee |
| Phone Number | (615) 255-0068 |
| Industry | manufacturing |
| CEO | A. J. Kazimi |
| Website | www.cumberlandpharma.com |
Financial Year:
Financial Overview (Dollars in Millions)
| Revenue | $37.9 |
| Operating Profit | $-6.4 |
| Net Income | $-6.4 |
| Net Cash | $-0.4 |
Profit Ratios
| Gross Margin | $31.3 |
| Operating Margin | -17 |
| Profit as % of Revenues | -485.5% |
| Profit as % of Assets | -8.2% |
| Profit as % of Stockholder Equity | -28.6% |
Management Effectiveness
| Return on Equity | -28.6% |
| Return on Assets | -8.5% |
| Turnover Ratio | 48.1% |
| EBITA | $-1.7 |
Balance Sheet and Cash Flow Measures
| Total Assets | $75.6 |
| Total Liabilities | $53 |
| Operating Cash Flow | $-0.6 |
| Investing Cash Flow | $0.1 |
| Financing Cash Flow | $0.2 |
